Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 60,490 Grace Therapeutics, Inc. shares (Form 4)

Traded Oct 1 to Oct 5, 2026 · Filed Oct 5, 2026

From Oct 1 to Oct 5, 2026, Opaleye Management Inc. (10% owner) bought 60,490 Grace Therapeutics, Inc. shares at an average US$2.05 for US$124K, leaving 2,858,657 shares. Filed Oct 5, 2026 (Form 4).

Bought
60,490 shares
Price
US$2.05 average (US$2.04 to US$2.07)
Value
US$124K
Holding after
2,858,657 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common Stock, par value $0.0001 per shareBuy38,796US$2.042,836,963Indirect
Oct 2, 2026Common Stock, par value $0.0001 per shareBuy20,000US$2.072,856,963Indirect
Oct 5, 2026Common Stock, par value $0.0001 per shareBuy1,694US$2.062,858,657Indirect

Source

View original at SEC

Related